Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • UK inflation holds steady at 2.2% in August
    • Why Europe will not catch up with the US
    • Nine killed and thousands injured as Hizbollah pagers explode in Lebanon
    • Exploding pagers join long history of killer communications devices
    • Charlie Mullins is back on Pimlico Plumbers’ home turf
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Why Europe will not catch up with the US
    • Kamala Harris admits she still has ‘to earn’ the Black male vote
    • Market speculation about the next Fed rate cut masks deeper issues
    • Music mogul Sean Combs charged with racketeering and sex trafficking
    • US delays decision on Nippon Steel’s $15bn takeover of US Steel
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • The fury of the frequent flyer
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Steve Cohen to step back from trading at hedge fund Point72
    • Reeves orders crackdown on government use of consultants
    • EU competition chief warns against weakening rules to create champions
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Meta faces hefty EU antitrust fine over classified ads practices
    • ‘No Man’s Sky’ and ‘Cyberpunk 2077’ show there is life after death for video-game flops
    • Amazon orders staff back to office five days a week
    • Data centres must work ‘within climate limits’, says Irish minister
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • BlackRock and Microsoft plan $30bn fund to invest in AI infrastructure
    • Steve Cohen to step back from trading at hedge fund Point72
    • BP’s US wind sale will not clear its strategic fog
    • Switzerland’s SIX explores launching crypto exchange
    • Vibes on the big day
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why Europe will not catch up with the US
    • The fury of the frequent flyer
    • Charlie Mullins is back on Pimlico Plumbers’ home turf
    • Draghi is trying to save Europe from itself
    • BP’s US wind sale will not clear its strategic fog
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Amazon orders staff back to office five days a week
    • FT and Schroders Business Book of the Year 2024 — the shortlist
    • Italy retains allure for rich Europeans fleeing higher taxes
    • The problem with panels
    • Tata chair on ‘painful’ transitions: ‘We have to do this’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Thoroughly modern Mayfair
    • Why every man needs a smart black hoodie
    • ‘No Man’s Sky’ and ‘Cyberpunk 2077’ show there is life after death for video-game flops
    • Tramp revamped: the return of a legendary nightclub
    • The brothers trying to save the British fountain pen
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Covid-19 vaccines

  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Bird flu and mpox show little learnt from Covid about future pandemics

    More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts

    Several workers dressed in white protective coveralls are attending to rows of chickens inside a poultry farm
  • Thursday, 12 September, 2024
    Special ReportFT Health: Communicable Diseases
    Public health in global south faces vaccine cold storage challenge

    Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks

    A female healthcare worker prepares a vaccine. Behind her in a chair is a woman and her baby
  • Wednesday, 28 August, 2024
    The FT ViewThe editorial board
    The disappointing international response to mpox

    Wealthy world must help Africa prevent a potential regional health catastrophe

    Elisabeth Furaha applies medication on the skin of her child Sagesse Hakizimana who is under treatment for Mpox
  • Friday, 16 August, 2024
    Pharmaceuticals sector
    BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial

    Jab makers fall behind Moderna in post-pandemic market with disappointing results

    A close up shot of a Covid vaccine being administered
  • Wednesday, 17 July, 2024
    European Union
    Brussels concealed Covid vaccine contracts details, court finds

    EU court rules that European Commission unlawfully withheld information about procurement

    European Commission president Ursula von der Leyen arrives at the European parliament in Strasbourg on Monday
  • Wednesday, 3 July, 2024
    GSK PLC
    GSK signs €1.4bn mRNA vaccine deal with troubled biotech CureVac

    New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group

    The GSK logo on its headquarters in london
  • Tuesday, 2 July, 2024
    Moderna
    Moderna secures partial victory in Covid vaccine legal fight

    Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules

    A patient receives a Moderna jab
  • Thursday, 27 June, 2024
    GSK PLC
    GSK shares fall as US narrows age recommendation for RSV vaccines

    Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer

    GSK Vaccines production line
  • Monday, 10 June, 2024
    Moderna
    Moderna hails successful trial of combined Covid and flu shot

    Vaccine maker to seek approval for jab as it tries to diversify product pipeline

    A vial of a Moderna Covid-19 vaccine
  • Thursday, 23 May, 2024
    LexDrugs research
    Cancer vaccines are finally showing promise Premium content

    As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease

    A person looks into microscope
  • Sunday, 19 May, 2024
    Coronavirus
    New Covid variants stoke fears of a summer surge in cases

    So-called FLiRT strains set to test effectiveness of vaccines against latest mutations

    A fan wears a Chicago White Sox Covid-19 mask during the regular season MLB game between the Cleveland Guardians and the Chicago White Sox
  • Friday, 17 May, 2024
    Moderna
    Moderna wins Covid jab patent dispute over Pfizer and BioNTech

    Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals

  • Friday, 10 May, 2024
    Novavax Inc
    Sanofi licensing deal doubles value of vaccine group Novavax

    Agreement worth up to $1.2bn includes plan for combined flu and Covid shots

    The logo of French drugmaker Sanofi on a building
  • Wednesday, 8 May, 2024
    The great pandemic vaccine bubble, charted

    Saving humanity’s a costly business

  • Wednesday, 8 May, 2024
    AstraZeneca PLC
    AstraZeneca withdraws Covid-19 vaccine

    Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab

    A person prepares a vaccination syringe
  • Monday, 22 April, 2024
    FT News Briefing podcast10 min listen
    Beijing bets on manufacturing

    Xi Jinping hopes manufacturing can offset the property slump

  • Monday, 22 April, 2024
    News in-depth
    Covid vaccine makers to clash in London over mRNA patent dispute

    Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform

    A woman receiving a dose of Moderna’s Covid vaccine
  • Monday, 15 April, 2024
    Hedge fund urges board shake-up at Novavax over struggling Covid vaccine

    Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak

    Syringes with needles are seen in front of a displayed Novavax logo
  • Thursday, 11 April, 2024
    Moderna puts plans for African vaccine plant on hold

    Pledges to invest in pandemic preparedness with facility in Kenya fall short as sales of Covid jabs decline

    A scientist works in the lab at Moderna in Cambridge, Massachusetts
  • Saturday, 30 March, 2024
    Adam Tooze
    Vaccine investment is a no-brainer — so why aren’t we doing it?

    Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster

    A healthworker in a face mask injects a Covid vaccine into a woman’s arm
  • Monday, 18 March, 2024
    Disease control and prevention
    Dispute over genomic databank undermines fight to thwart next pathogen

    Officials warn weaknesses in surveillance will hinder vaccine development as countries struggle to agree accord

    A scientist demonstrates pipetting viscous genomic DNA
  • Tuesday, 12 March, 2024
    Anjana Ahuja
    The UK could be a vaccine superpower, but it needs a booster

    We risk forgetting the lessons of the Covid pandemic

    Ewan White illustration of hands in black gloves holding a syringe to draw liquid from a vial coloured in the Union Jack
  • Sunday, 28 January, 2024
    The FT ViewThe editorial board
    The worrying return of a nasty virus

    Better awareness and access are needed to rebuild measles vaccination rates

    A toddler in her mothers arms while she is inoculated in the arm
  • Thursday, 4 January, 2024
    Raymond Duch
    It’s time to start using cash incentives to boost vaccine take-up

    A trial of $3 payments for getting a Covid jab in rural Ghana offers a game-changing way to meet public health goals

    A nurse wearing a facemask vaccinates a man in a Ghana hospital
  • Sunday, 24 December, 2023
    Coronavirus
    New Covid variant gains ground in US ahead of holiday season

    Americans’ interest in vaccinations has flagged despite efforts to boost uptake of latest jab

    A shopper wearing a mask and carrying bags in San Francisco
Previous page You are on page 1 Next page

Recommended

Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Covid vaccine development: The shots available and the doses administered
In graphics: the UK vaccine supply chain
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
Coronavirus tracker

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In